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ABSTRACT
Objective: To validate the utilities of Berlin, STOP
and STOP-BANG Questionnaires, other patient
characteristics, comorbidities, Epworth Sleepiness
Scale (ESS), fractional exhaled nitric oxide (FENO) and
blood markers for the prediction of sleep disordered
breathing (SDB) on limited polygraphy.
Setting: North Glasgow Sleep Service (a tertiary
referral centre).
Participants: 129 consecutive patients, aged
≥16 years, referred to the sleep clinic for assessment
of possible obstructive sleep apnoea.
Interventions: We selected cut-points of apnoea
hypopnoea index (AHI) of ≥5 and ≥15/h from their
home polygraphy and determined associations of these
with individual symptoms, questionnaire scores and
other results. Receiver operating characteristic analysis
and univariate and multivariate logistic regression were
used to explore these.
Primary and secondary outcomes measures:
Primary: The utility of STOP, STOP-BANG and Berlin
Questionnaires for prediction of SDB. Secondary:
The utility of other measures for prediction of SDB.
Results: AHI was ≥5 in 97 patients and ≥15 in
56 patients. STOP and STOP-BANG scores were
associated with both AHI cut-points but results with
ESS and Berlin Questionnaire scores were negative.
STOP-BANG had a negative predictive value 1.00
(0.77–1.00) for an AHI ≥15 with a score ≥3 predicting
AHI ≥5 with sensitivity 0.93 (95% CI 0.84 to 0.98) and
accuracy 79%, while a score ≥6 predicted AHI ≥15
with specificity 0.78 (0.65 to 0.88) and accuracy 72%.
Neck circumference ≥17 inch and presence of
witnessed apnoeas were independent predictors of
SDB.
Conclusions: STOP and STOP-BANG Questionnaires
have utility for the prediction of SDB in the sleep clinic
population. Modification of the STOP-BANG
Questionnaire merits further study in this and other
patient groups.
INTRODUCTION
Obstructive sleep apnoea syndrome (OSAS)
is common with prevalence of approximately
4% in middle-aged men and 2% in middle-
aged women.1 Frequent partial (hypopnoea)
or complete (apnoea) upper airway collapse
during sleep leads to oxygen desaturation,
increased respiratory effort, arousal and sleep
fragmentation.2 Patients typically present with
witnessed apnoeas, loud snoring and exces-
sive daytime somnolence.3 The syndrome is
associated with impaired quality of life,4 cog-
nitive functioning and work performance,5
and with increased risk of road traffic acci-
dents.6 OSAS is considered an independent
risk factor for hypertension,7 and has associa-
tions with coronary disease, stroke, heart
failure, arrhythmias,8 metabolic syndrome9
and type 2 diabetes.10
Despite the substantial burden of this
disease, it is under-recognised. One study
estimated that 93% of women and 82% of
men with moderate-to-severe OSAS were not
clinically diagnosed,11 and more recent data
support this finding.12 Sleep studies are
required for OSAS diagnosis but are expen-
sive and not widely available.3 Given the
recent increases in childhood13 and adult-
hood obesity,14 the workload for sleep clinics
Strengths and limitations of this study
▪ This is the first study to prospectively evaluate
the utility of the Berlin, STOP and STOP-BANG
Questionnaires in the prediction of sleep disor-
dered breathing in the population referred to a
sleep service for assessment of possible
obstructive sleep apnoea (OSA).
▪ The results of this study show that the STOP and
STOP-BANG, but not the Berlin Questionnaire,
have utility for prediction of sleep disordered
breathing in the sleep clinic population.
▪ This study uses home unattended limited sleep
studies rather than in-hospital attended full poly-
somnography; however, this is considered stand-
ard clinical practice in the UK and is considered
an acceptable method for diagnosis of OSA by
the American Academy of Sleep Medicine.
▪ The sample size limits the conclusions that can
be drawn from the multivariate analysis;
however, this was a secondary objective of the
study.
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and sleep laboratories will increase. Predictors of sleep
disordered breathing (SDB) are required to allow recog-
nition of OSAS and prioritisation of investigations.
Several questionnaires have been designed to screen
for SDB in different populations. The Berlin
Questionnaire was first validated in primary care against
portable unattended sleep studies and a ‘high risk’ score
predicted a respiratory disturbance index >5 with sensitiv-
ity 0.86, specificity 0.77, positive predictive value (PPV)
0.89 and likelihood ratio 3.79.15 Its utilisation in other
populations has been assessed with variable success.16–22
The STOP and STOP-BANG Questionnaires were origin-
ally validated in surgical patients using in-hospital
attended polysomnography.23 For prediction of apnoea
hypopnoea index (AHI) greater than 5, 15 and 30, sensi-
tivities for the STOP and STOP-BANG Questionnaires
were 65.6%, 74.3% and 79.5%, and 83.9%, 92.9% and
100%, respectively. The Berlin and STOP Questionnaires
have been compared in a cohort of surgical patients24
and the STOP and STOP-BANG Questionnaires have
been compared in a large study involving several distinct
cardiovascular and respiratory disease cohorts.25 No study
has, however, compared these screening tools in a sleep
service-referred population. Finally, because of rising
obesity rates, there is the potential for increasing recogni-
tion of SDB in primary care, and in the face of this evolu-
tion in sleep clinic practice it is therefore necessary to
update and re-evaluate established assessment tools.
The objective of this study was, first, to compare the
utility of Berlin, STOP and STOP-BANG Questionnaires
for prediction of SDB in a population referred to the
sleep clinic for assessment of possible OSA. Second, we
sought to identify the most important variables from
these questionnaires and routine sleep clinic assessment
that might be utilised in the development of a compos-
ite predictive score for future use in this population.
METHODS
This was a prospective observational study conducted
during May–December 2012. Study participants received
an information sheet and provided informed consent.
Participants
Consecutive patients aged ≥16 years referred to the
North Glasgow Sleep Service (a tertiary centre) for
assessment of possible OSA were invited to participate.
Measurements
Height, weight, body mass index (BMI), neck circumfer-
ence, blood pressure and Epworth Sleepiness Scale
(ESS)26 were completed at the Sleep Clinic. Participants
attended the Sleep Laboratory on a separate day so that
a Sleep Physiologist could provide, and instruct on
fitting, a sleep study device. On that occasion, relevant
symptoms and comorbidities were recorded, Mallampati
score was assessed and the Berlin and STOP-BANG
Questionnaires were completed. Blood samples
including a non-fasting lipid profile, glycated haemoglo-
bin (HbA1c) and C reactive protein were taken. Two
fractional exhaled nitric oxide (FENO) measurements
were taken using the NIOX MINO (Aerocrine, Solna,
Sweden), and the mean calculated.
Sleep studies
Unattended home limited polygraphy sleep studies were
performed using the SOMNOmedics SOMNOscreen kit
(Randersacker , Germany) with channels that recorded
body position, thoracoabdominal movements, oronasal
airflow, heart rate, pulse oximetry and snoring. Sleep
study scoring by experienced Sleep Physiologists was in
accordance with accepted guidelines.27 An apnoea was
defined as cessation of nasal flow for ≥10 s, while a
hypnoea was defined as 50% reduction in nasal flow for
≥10 s, or lesser reduction in flow associated with oxygen
desaturation of ≥4%.
The ESS, Berlin, STOP and STOP-BANG Questionnaires
The ESS is a validated measure of daytime sleepiness
including eight questions, each with four possible
responses, that assess the likelihood of dozing in different
situations; a score of ≥11/24 denotes excessive daytime
somnolence.26 The Berlin Questionnaire includes ques-
tions in three categories that relate, first, to snoring and
witnessed apnoeas, second, to tiredness, fatigue and
sleepiness, and third, to hypertension and obesity.15 High
risk of OSA is defined by scoring positively in ≥2 categor-
ies. The STOP Questionnaire includes four yes/no ques-
tions that relate to Snoring, Tiredness, Observed apnoeas
and high blood Pressure.23 High risk of OSA is defined as
a score of ≥2. The STOP-BANG Questionnaire includes
four additional questions relating to BMI, age, neck cir-
cumference and gender, and high risk of OSA is defined
as a score of ≥3.23
Statistical analyses
Statistical analyses were carried out using GraphPad
Prism 5, IBM SPSS Statistics V.19 and STATA V.12.
Normality of data was checked using the D’Agostino &
Pearson omnibus normality test. A priori, two cut-points
were chosen for AHI ≥5 events/h (the standard cut-
point for the diagnosis of OSA)28 and ≥15 events/h, to
predict significant SDB (the standard cut-point for initi-
ating continuous positive airway pressure (CPAP)
therapy).28 Groups were compared using unpaired
t tests, Mann-Whitney tests and Fisher’s exact tests as
appropriate. Sensitivities, specificities, PPV and negative
predictive value (NPV), positive and negative likelihood
ratios and overall accuracies were calculated for each of
the questionnaires for prediction of SDB as defined by
AHI cut-points ≥5 and ≥15. Associations between indi-
vidual variables and each of the cut-points for AHI were
explored using univariate and multivariate logistic
regression. For multivariate analysis, in a few cases where
BMI was known but neck circumference was not known,
a value for the neck circumference was imputed using
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linear regression with BMI as the independent value.
This allowed for a dataset of 116 cases with all of the
variables known or imputed to be built to identify inde-
pendent variables for inclusion in a composite score.
Receiver operating characteristic (ROC) curve analysis
was used to assess predictive value and an area under
the curve (AUC) >0.7 was considered clinically signifi-
cant. Data are presented as mean (SD), median (IQR)
and proportion (percentage), unless stated otherwise.
A p value <0.05 was considered statistically significant.
RESULTS
In total 150 participants participated in this study, of
which 129 had adequate sleep study data and were
included in the analysis. AHI was ≥5 in 97/129 (75%)
and ≥15 in 56/129 (43%). Overall, 82 (64%) were male,
mean (SD) age was 49 (11) years, and median (IQR)
BMI was 32 (29–39) kg/m2.
Predicting SDB: patient characteristics
An AHI <5 (‘rule-out measurement’) was associated with
female sex, younger age, lower weight and neck circum-
ference, less frequently reported witnessed apnoeas,
higher high-density lipoprotein (HDL) cholesterol, and
lower triglycerides, cholesterol/HDL and HbA1c (see
table 1). An AHI ≥15 (‘rule-in measurement’) was asso-
ciated with male sex, obesity, higher weight, BMI and
neck circumference, more frequently reported hyperten-
sion and witnessed apnoeas, lower HDL cholesterol, and
higher triglycerides, cholesterol/HDL and HbA1c.
Predicting SDB: ESS, Berlin, STOP and STOP-BANG
The ESS and Berlin questionnaire outcomes were not
associated with either AHI cut-point. An AHI <5 was
associated with lower STOP and STOP-BANG scores and
fewer participants being classified as ‘high risk’ for OSA
by both STOP and STOP-BANG Questionnaires (see
tables 2–4). An AHI ≥15 was associated with higher
STOP and STOP-BANG scores and more participants
being classified as ‘high risk’ for OSA by the
STOP-BANG Questionnaire but not by the STOP
questionnaire.
For the AHI cut-point of ≥5, the Berlin, STOP and
STOP-BANG Questionnaires had high sensitivities, mod-
erate PPVs and poor specificities and NPVs for predic-
tion of SDB. The STOP-BANG Questionnaire
performed best with an overall accuracy of 79%. For the
AHI cut-point of ≥15, the Berlin Questionnaire had
high sensitivity but otherwise performed poorly. The
STOP and STOP-BANG Questionnaires had high sensi-
tivities and NPVs. Again, the STOP-BANG Questionnaire
performed best, but with a low overall accuracy of 56%.
The low negative likelihood ratios for the STOP and
STOP-BANG Questionnaires at both cut-points indicate
that these questionnaires have value in excluding
disease. As shown in table 4, the cut-points for the
STOP-BANG score that was associated with best overall
accuracy were ≥3 and ≥6 for prediction of AHI ≥5 and
≥15, respectively.
SDB versus no SDB: predictors and a composite score
For the cut-point of AHI of ≥5, univariate logistic regres-
sion showed significant associations for age, gender,
weight, neck circumference, witnessed apnoeas, trigly-
cerides and cholesterol/HDL (p<0.05; see tables 5 and
6 and figure 1). For the cut-point of ≥15, significant
associations were found for gender, weight, BMI, neck
circumference, witnessed apnoeas, obesity, hypertension,
FENO and cholesterol/HDL (p<0.05). Multivariate logis-
tic regression based on the significant variables from
univariate logistic regression showed that for both cut-
points neck circumference and witnessed apnoeas were
independent predictors of SDB. For the cut-point of
AHI of ≥5, in a model incorporating neck circumfer-
ence and witnessed apnoeas, the probability of SDB was
0.94 for individuals with neck circumference ≥17 inch
and witnessed apnoeas (sensitivity 84%, overall accuracy
77%, ROC AUC 0.768, p<0.001). For the cut-point of
AHI ≥15, the probability of SDB was 0.69 for individuals
with neck circumference ≥17 inch and witnessed
apnoeas (specificity 80%, overall accuracy 69%, ROC
AUC 0.722, p<0.001).
DISCUSSION
This is the first study to prospectively evaluate the utility
of the Berlin, STOP and STOP-BANG Questionnaires in
prediction of SDB in a population referred to a tertiary
sleep service for assessment of possible OSA. We found
that in this population the Berlin Questionnaire had no
significant association with cut-points of ≥5 or ≥15 for
AHI, but that both the STOP and STOP-BANG scores
were significantly associated with both cut-points. The
STOP-BANG Questionnaire had better performance for
the prediction of OSA on home sleep study, and differ-
ent cut-points for the STOP-BANG score could be
selected depending on the preference to exclude SDB
(score <3) or predict SDB (score ≥6). In addition, we
found notable associations between sleep study results
and several patient characteristics. In particular, neck cir-
cumference and witnessed apnoeas were found to be
independent predictors of SDB in our population.
In our study, the Berlin Questionnaire was almost ubi-
quitously positive (116 of 125 participants had a positive
result) and the positivity rate did not differ between
those with and without SDB. This was expected as this
questionnaire was designed for primary care assessment
and our study population consisted of individuals
referred from primary care with symptoms suggestive of
SDB. Our results indicate that the Berlin Questionnaire
is not useful in the prediction of SDB in the sleep clinic
referral population and this is consistent with previous
reports.19 The high sensitivities obtained for both AHI
cut-points support previous findings that the Berlin
Questionnaire may have a role as a ‘rule-out’
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measurement in the primary care or screening
setting,15 17 20 24 though there have been some conflict-
ing results, suggesting that it does not have adequate dis-
criminatory power.16 22
In our study, ESS data indicated that two-thirds of par-
ticipants had excessive daytime somnolence (ESS ≥11);
however, scores were similar in individuals with or
without SDB. Therefore, at least in the sleep clinic popu-
lation, the ESS is not useful for the prediction of SDB. It
may be of value perhaps if it is combined with other
measures, including those highlighted in this study, in
prediction of compliance with and benefit from OSA
treatment. Further research is required to address this
question. The exhaled nitric oxide levels were not sig-
nificantly different between individuals with or without
SDB, whether defined by an AHI cut-point of ≥5 or
≥15. There are conflicting data in the literature regard-
ing whether FENO is associated with SDB;
29–32 however,
Table 1 Comparison of patient characteristics including anthropometric measurements, comorbidities, symptoms,
inflammatory markers, lipid profile and oximetry between groups without and with SDB as defined by AHI <5 and ≥15 events/h
AHI <5 AHI ≥5 p Value AHI <15 AHI ≥15 p Value
Male gender 15/32 (47%) 67/97 (69%) 0.034 38/73 (52%) 44/56 (79%) 0.003
Age (years) 44 (12) 51 (11) 0.004 48 (13) 51 (9) 0.103
Weight (kg) 89 (19) 101 (22) 0.022 92 (21) 107 (20) 0.001
BMI (kg/m2) 31 (28–36) 33 (29–40) 0.118 31 (27–36) 34 (31–41) 0.009
Obesity (BMI ≥30 kg/m2) 18/28 (64%) 61/85 (72%) 0.482 38/63 (60%) 41/50 (82%) 0.014
Neck circumference (inch) 15 (2) 17 (2) <0.001 16 (2) 17 (1) <0.001
Neck circumference ≥17 inch 4/22 (18%) 45/76 (59%) 0.001 18/54 (33%) 31/44 (70%) <0.001
Mallampati 2 (1) 2 (1) 0.192 2 (1) 2 (1) 0.900
SBP (mm Hg) 134 (17) 136 (16) 0.480 134 (15) 138 (18) 0.194
DBP (mm Hg) 82 (11) 83 (9) 0.528 81 (10) 85 (10) 0.086
Diabetes 2/32 (6%) 6/97 (6%) 1.000 4/73 (5%) 4/56 (7%) 0.727
Hypertension 7/32 (22%) 36/97 (37%) 0.134 18/73 (25%) 25/56 (45%) 0.024
Hyperlipidaemia 2/32 (6%) 18/97 (19%) 0.156 10/73 (14%) 10/56 (18%) 0.625
Loud snorer 28/32 (88%) 92/97 (95%) 0.224 65/73 (89%) 55/56 (98%) 0.077
Witnessed apnoeas 15/32 (47%) 72/97 (74%) 0.008 40/73 (55%) 47/56 (84%) <0.001
Nocturia* 11/32 (34%) 38/97 (39%) 0.679 26/73 (36%) 23/56 (41%) 0.585
Nocturnal wakenings* 18/32 (56%) 65/97 (67%) 0.293 46/73 (63%) 37/56 (66%) 0.853
Nocturnal choking 15/32 (47%) 35/97 (36%) 0.301 28/73 (38%) 22/56 (39%) 1.000
Nocturnal gasping 11/32 (34%) 38/97 (39%) 0.679 26/73 (36%) 23/56 (41%) 0.585
FENO (ppb) 15 (12–25) 18 (12–26) 0.595 15 (11–24) 19 (12–27) 0.050
Cholesterol (mmol/L) 5.2 (1.1) 5.4 (1.0) 0.431 5.3 (1.1) 5.4 (0.9) 0.674
HDL cholesterol (mmol/L) 1.3 (1.0–1.5) 1.1 (1.0–1.3) 0.008 1.2 (1.0–1.4) 1.1 (1.0–1.2) 0.016
Triglycerides (mmol/L) 1.9 (1.0–2.5) 2.2 (1.5–3.2) 0.015 1.9 (1.3–2.9) 2.3 (1.6–3.2) 0.042
Cholesterol/HDL 4.1 (3.3–5.0) 4.7 (3.8–5.7) 0.011 4.3 (3.5–5.6) 4.8 (4.0–5.8) 0.022
HbA1c (mmol/mol) 34 (32–37) 38 (36–41) 0.001 36 (33–39) 38 (36–42) 0.002
CRP 3.0 (1.2–8.5) 3.8 (1.4–7.5) 0.608 3.0 (1.3–7.6) 4.3 (1.4–8.6) 0.173
Data presented as mean (SD), median (IQR) or proportion (percentage) as appropriate. Significant differences in italics.
*≥2/Night.
AHI, apnoea hypopnoea index; BMI, body mass index; CRP, C reactive protein; DBP, diastolic blood pressure; FENO, fraction of exhaled nitric
oxide; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; ODI, oxygen desaturation index; SBP, systolic blood pressure; SDB,
sleep disordered breathing.
Table 2 Comparison of results of ESS and Berlin, STOP and STOP-BANG Questionnaires between groups without and with
SDB as defined by AHI <5 and ≥15 events/h
AHI <5 AHI ≥5 p Value AHI <15 AHI ≥15 p Value
ESS score 13 (8–16) 13 (7–17) 0.845 13 (7–16) 13 (9–18) 0.476
ESS positive (≥11/24) 17/28 (61%) 63/92 (68%) 0.496 42/66 (64%) 38/54 (70%) 0.560
Berlin positive 29/31 (94%) 87/94 (93%) 1.000 65/71 (92%) 51/54 (94%) 0.731
STOP score 2.5 (2–3) 3 (2–3) 0.011 3 (2–3) 3 (3–3.5) <0.001
STOP positive (≥2/4) 27/32 (84%) 93/96 (97%) 0.023 66/73 (90%) 54/55 (98%) 0.137
STOP-BANG score 4 (2–5) 5 (5–6) <0.001 5 (2–5) 6 (5–6) <0.001
STOP-BANG positive (≥3/8) 21/30 (70%) 88/93 (95%) <0.001 54/68 (79%) 55/55 (100%) <0.001
Data presented as median (IQR) or proportion (percentage) as appropriate. Significant differences in italics.
ESS, Epworth Sleepiness Scale; SDB, sleep disordered breathing.
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our results suggest that it does not have utility in predic-
tion of SDB; further work is required to clarify this.
We found that the STOP and STOP-BANG
Questionnaires have utility in the prediction of SDB in
the sleep clinic population, and that STOP-BANG was
superior, with higher overall predictive accuracy. The
STOP and STOP-BANG Questionnaires were developed
and validated in a surgical population using
in-laboratory polysomnography23 and have subsequently
been studied in a cardiovascular disease population.25
Our results are in agreement with these two earlier
studies as regards the increased predictive value of
STOP-BANG over STOP. In contrast to these earlier
studies, however, we found sensitivities to be higher and
specificities to be lower for both cut-points of AHI. We
suggest that of the two AHI cut-points, ≥15 events/h is
the more important, being diagnostic of at least moder-
ate SDB and also an indication for CPAP treatment. At
this cut-point, STOP and STOP-BANG performed with
high sensitivities and negative predictive values
(STOP-BANG being superior to STOP), indicating that
these questionnaires are more useful in excluding sig-
nificant SDB. This is further corroborated by the nega-
tive likelihood ratios of <0.2 obtained for STOP and
STOP-BANG that also indicate that these questionnaires
are most useful in ruling out SDB. STOP-BANG may be
of value in the primary care setting, perhaps if com-
bined with type IV portable monitoring sleep studies, to
determine requirement for sleep clinic review and more
detailed polygraphy.
At the AHI cut-point of ≥15, STOP-BANG had sensitiv-
ity and NPV of 100%, and since this is the standard cut-
point conventionally used to determine need for
CPAP,28 we suggest that the STOP-BANG Questionnaire
is the preferred tool for prediction of SDB in the sleep
clinic setting of those currently available. STOP-BANG,
perhaps with modifications, merits further evaluation for
the prediction of SDB in the sleep clinic population
and, more importantly, its utility in prediction of clinical
outcomes including treatment success should be
assessed.
The original STOP-BANG Questionnaire uses a cut-
point of ≥3 to predict SDB.23 However, in our study, we
show that different cut-points can be selected depending
on the preference to rule-in or rule-out SDB. A score of
≥3 had the highest overall accuracy and a sensitivity of
0.93 for the AHI cut-point of ≥5, whereas a score of ≥6
had the highest overall accuracy and a specificity of 0.78
for the AHI cut-point of ≥15. Two other studies have
examined the usefulness of different cut-points for the
STOP-BANG score.33 34 In the obese, a score of ≥3 was
associated with a sensitivity of 0.90 for predicting an AHI
>5, while a score of ≥6 had a specificity of 0.88 for pre-
dicting an AHI >15 and similar results have been
obtained in the morbidly obese33 and in a surgical popu-
lation.34 Thus, in the sleep clinic setting where the
ultimate goal is to identify patients requiring CPAP, a
higher cut-point for STOP-BANG may be preferred,
whereas in a primary care setting where the priority is
not to miss disease, a lower cut-point may be chosen.
The STOP-BANG Questionnaire is, however, still an
imperfect tool for prediction of results on home polygra-
phy. Accordingly, the secondary objective of our study
was to identify variables for inclusion in a locally devel-
oped composite score for future validation in the sleep
clinic and potentially wider population. Univariate ana-
lysis showed several significant, expected associations for
both cut-points of AHI. Using multivariate analysis, neck
circumference ≥17 inch and the presence of witnessed
apnoeas were independent predictors of SDB. This is
not a novel finding, but it does support the robustness
of our data. Particularly when SDB was defined by an
AHI cut-point of ≥5, the regression model derived indi-
cated a high probability of SDB of 0.94 if both factors
were present. The STOP-BANG Questionnaire, of
course, includes both these variables, and it is possible
that adjustment of the inclusion variables, or their
weighting, might improve its performance. In future
work, we aim to validate a simple composite score based
on these two variables in a modification of STOP-BANG,
to determine utility for predicting sleep study data and
outcomes with treatment.
Table 3 Sensitivities, specificities, PPV, NPV, LR+, LR− and overall accuracies of the Berlin, STOP and STOP-BANG
Questionnaires for prediction of significant SDB as defined by: model A: AHI ≥5 events/h; model B: ≥15 events/h
Sensitivity Specificity PPV NPV LR+ LR−
Accuracy
(%)
Model A
Berlin 0.93 (0.85 to 0.97) 0.06 (0.01 to 0.21) 0.75 (0.66 to 0.83) 0.22 (0.03 to 0.60) 0.99 1.15 71
STOP 0.97 (0.91 to 0.99) 0.16 (0.05 to 0.33) 0.78 (0.69 to 0.85) 0.62 (0.24 to 0.91) 1.15 0.20 77
STOP-BANG 0.95 (0.88 to 0.98) 0.30 (0.15 to 0.49) 0.81 (0.72 to 0.88) 0.64 (0.35 to 0.87) 1.35 0.18 79
Model B
Berlin 0.94 (0.85 to 0.99) 0.08 (0.03 to 0.17) 0.44 (0.35 to 0.53) 0.67 (0.30 to 0.92) 1.03 0.66 46
STOP 0.98 (0.90 to 1.00) 0.10 (0.04 to 0.19) 0.45 (0.36 to 0.54) 0.88 (0.47 to 1.00) 1.09 0.19 48
STOP-BANG 1.00 (0.94 to 1.00) 0.21 (0.12 to 0.32) 0.50 (0.41 to 0.60) 1.00 (0.77 to 1.00) 1.26 0.00 56
Data presented with 95% CIs.
AHI, apnoea hypopnoea index; LR+, likelihood ratios positive; LR−, likelihood ratios negative; NPV, negative predictive values; PPV, positive
predictive values; SDB, sleep disordered breathing.
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Table 4 Sensitivities, specificities, PPV, NPV, LR+, LR− and overall accuracies of different cut-points of the STOP-BANG questionnaire for prediction of significant SDB
as defined by: model A: AHI ≥5 events/h; model B: ≥15 events/h
STOP-BANG
cut-point (/8)
Proportion
positive SB Sensitivity Specificity PPV NPV LR+ LR−
Accuracy
(%)
Model A
≥2 92/96 0.99 (0.92 to 1.00) 0.12 (0.03 to 0.32) 0.77 (0.67 to 0.85) 0.75 (0.19 to 0.99) 1.13 0.11 77
≥3 82/96 0.93 (0.84 to 0.98) 0.38 (0.19 to 0.59) 0.82 (0.72 to 0.89) 0.64 (0.35 to 0.87) 1.49 0.18 79
≥4 79/96 0.90 (0.81 to 0.96) 0.42 (0.22 to 0.63) 0.82 (0.72 to 0.90) 0.59 (0.33 to 0.82) 1.55 0.23 78
≥5 67/96 0.81 (0.70 to 0.89) 0.62 (0.41 to 0.81) 0.87 (0.76 to 0.94) 0.52 (0.32 to 0.71) 2.15 0.31 76
≥6 38/96 0.46 (0.34 to 0.58) 0.79 (0.58 to 0.93) 0.87 (0.72 to 0.96) 0.33 (0.21 to 0.46) 2.20 0.68 54
≥7 15/96 0.18 (0.10 to 0.29) 0.92 (0.73 to 0.99) 0.87 (0.60 to 0.98) 0.27 (0.18 to 0.38) 2.17 0.89 36
8 5/96 0.07 (0.02 to 0.15) 1.00 (0.86 to 1.00) 1.00 (0.48 to 1.00) 0.26 (0.18 to 0.37) – 0.93 30
Model B
≥2 92/96 1.00 (0.91 to 1.00) 0.07 (0.02 to 0.18) 0.45 (0.34 to 0.55) 1.00 (0.40 to 1.00) 1.08 0 47
≥3 82/96 1.00 (0.91 to 1.00) 0.25 (0.15 to 0.39) 0.50 (0.39 to 0.61) 1.00 (0.77 to 1.00) 1.34 0 57
≥4 79/96 1.00 (0.91 to 1.00) 0.31 (0.19 to 0.45) 0.52 (0.40 to 0.63) 1.00 (0.80 to 1.00) 1.45 0 60
≥5 67/96 0.93 (0.80 to 0.98) 0.47 (0.34 to 0.61) 0.57 (0.44 to 0.69) 0.90 (0.73 to 0.98) 1.76 0.15 67
≥6 38/96 0.63 (0.47 to 0.78) 0.78 (0.65 to 0.88) 0.68 (0.51 to 0.82) 0.74 (0.61 to 0.85) 2.91 0.47 72
≥7 15/96 0.22 (0.11 to 0.38) 0.89 (0.78 to 0.96) 0.60 (0.32 to 0.84) 0.60 (0.49 to 0.71) 2.01 0.88 60
8 5/96 0.10 (0.03 to 0.23) 0.98 (0.90 to 1.00) 0.80 (0.28 to 0.99) 0.59 (0.48 to 0.70) 5.36 0.92 60
Data presented with 95% CIs.
AHI, apnoea hypopnoea index; LR+, likelihood ratios positive; LR−, likelihood ratios negative; NPV, negative predictive values; PPV, positive predictive values; SDB, sleep disordered breathing.
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Ultimately, a predictive tool that can be utilised in
primary care is the goal. Our results indicate low specifi-
city of STOP-BANG, and therefore in its current form, if
used in primary care to identify patients requiring refer-
ral for further assessment, it is likely to result in a signifi-
cant percentage of patients being referred unnecessarily
(false positives). It is hoped that a modified
STOP-BANG with improved specificity, while not com-
promising sensitivity, may be developed that can be used
safely in primary care for identification of patients
requiring referral to sleep services. Of upmost import-
ance too is the prediction of treatment outcome.
Non-adherence to CPAP treatment occurs between 46%
and 83%.35 36 Prediction of poor adherence by
STOP-BANG or other similar tools would allow greater
attention to interventions to improve adherence in
patients more likely to default from treatment. The
authors are not aware of any studies investigating this
question and future research should explore this import-
ant issue.
A possible limitation of our study was that SDB was
characterised using home unattended limited sleep
studies rather than in-hospital attended full polysomno-
graphy. The latter is considered the gold standard for
diagnosis of SDB but is more expensive, less easily
accessed and potentially unrepresentative with sleep in
an unfamiliar environment. Home unattended and
in-hospital attended sleep studies have previously been
shown to produce similar results.37 Accordingly, home
testing with portable monitors is standard clinical prac-
tice in the UK, and is now considered an acceptable
method for diagnosis of OSA by the American Academy
of Sleep Medicine.28 The sample size limits the conclu-
sions that can be drawn from multivariate analysis;
however, this was a secondary objective of the current
study. It is possible that variables predictive of SDB on
univariate analysis in this cohort would have been identi-
fied as independently predictive in multivariate models
in a larger population. The results of this study allow us,
and potentially others, to focus future work to validate
more extensively the results obtained until now. We
chose AHI cut-points of ≥5 and ≥15 to define significant
SDB. This was based on the consensus guideline pro-
duced by the Adult Obstructive Sleep Apnea Task Force
of the American Academy of Sleep Medicine that states
that diagnosis of OSA is based on a cut-point of >15
events/h or >5 events/h with relevant symptoms, and
that CPAP is indicated for treatment of moderate-
to-severe OSA with ≥15 events/h.28 Although the cut-
point of >30 events/h is consistent with severe OSA, we
suggest that this cut-point is less relevant clinically from
a diagnostic perspective or from that of determining
treatment. Finally, owing to the prospective design of
our study, we cannot comment on the relative value of
other tools developed for prediction of OSA such as the
Table 5 Probabilities of SDB using a composite score
based on neck circumference (≥17 or <17 inch) and
presence (1) or absence (0) of witnessed apnoeas derived
from logistic regression models
Neck circumference (inch)
Witnessed
apnoeas
Model A 0 1
<17 0.47 0.75
≥17 0.83 0.94
Model B 0 1
<17 0.17 0.40
≥17 0.40 0.69
SDB defined by: A: AHI ≥5 events/h; B: ≥15 events/h.
Table 6 Sensitivities, specificities, PPV, NPV and overall accuracies of logistic models for prediction of SDB as defined by:
A: AHI ≥5 events/h; predict SDB unless neck <17 inch and witnessed apnoeas absent; B: AHI ≥15 events/h; predict SDB
only if neck ≥17 inch and witnessed apnoeas present
Model Sensitivity Specificity PPV NPV Accuracy (%)
A 0.84 (0.75 to 0.91) 0.54 (0.34 to 0.72) 0.85 (0.76 to 0.92) 0.52 (0.32 to 0.71) 77
B 0.56 (0.41 to 0.70) 0.80 (0.68 to 0.89) 0.69 (0.53 to 0.82) 0.69 (0.57 to 0.79) 69
Data presented with 95% CIs.
AHI, apnoea hypopnoea index; LR+, likelihood ratios positive; LR−, likelihood ratios negative; NPV, negative predictive values; PPV, positive
predictive values; SDB, sleep disordered breathing.
Figure 1 Receiver operating characteristic (ROC) curves of
logistic models for prediction of sleep disordered breathing
(SDB) as defined by: model A: apnoea hypopnoea index
(AHI) ≥5 events/h; predict SDB unless neck <17 inch and
witnessed apnoeas absent; model B: AHI ≥15 events/h;
predict SDB only if neck ≥17 inch and witnessed apnoeas
present.
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Sleep Apnea Clinical Score38 and American Society of
Anesthesiologists Checklist.39 To compare their utility
with that of the Berlin, STOP and STOP-BANG
Questionnaires in the population referred to, the sleep
service would require a further study.
In conclusion, the Berlin Questionnaire was not useful
in the prediction of SDB within our sleep clinic popula-
tion. The STOP-BANG Questionnaire had superior pre-
dictive performance to the STOP Questionnaire at both
cut-points of AHI (≥5 and ≥15). A STOP-BANG score of
≥3 had the highest overall accuracy and a sensitivity of
0.93 for the prediction of an AHI ≥5, while a score of ≥6
had the highest overall accuracy and a specificity of 0.78
for the prediction of an AHI ≥15. Future work will valid-
ate a composite score including neck circumference
≥17 inch and the presence of witnessed apnoeas for the
prediction of SDB in the sleep clinic referral population.
An optimised composite score could then be evaluated in
primary care and against treatment outcomes, with our
overall aim being to provide required tools for use in the
expanded and consolidated sleep services that are now
necessary given the current obesity and OSA epidemics.
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